Evidence map›Paper›PMID 40121355›Full record

ArticleCommunications chemistry2025

Synthesis and structural analysis of dinucleotides containing 2',3'-trans-bridged nucleic acids with trans-5,6- or 5,7-fused ring skeleton.

Takashi Osawa, Ryota Nakanishi, Keito Uda, So Muramoto, Satoshi Obika

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Takashi OsawaGraduate School of Pharmaceutical Science, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.ORCID http://orcid.org/0009-0004-5304-3861
Ryota NakanishiGraduate School of Pharmaceutical Science, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Keito UdaGraduate School of Pharmaceutical Science, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
So MuramotoGraduate School of Pharmaceutical Science, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Satoshi ObikaGraduate School of Pharmaceutical Science, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan. obika@phs.osaka-u.ac.jp.ORCID http://orcid.org/0000-0002-6842-6812

Funding

Japan Agency for Medical Research and Development (AMED) JP19am0401003, JP21ae0121022, JP21ae0121023 and JP21ae0121024MEXT | Japan Society for the Promotion of Science (JSPS) JP20K15401, JP23K04930, JP24H00839, and JP24H00840
6 · The paper itself

Abstract

Artificial nucleic acids in which the conformation of the sugar or phosphate backbone of the oligonucleotide is appropriately fixed can form stable duplexes. In this study, we designed dinucleotides containing 2',3'-trans-bridged nucleic acids (2',3'-trans-BNAs) based on the idea that the sugar conformation and torsions angles δ, ε, ζ, α, and β of the backbone can be controlled by a 5,6- or 5,7-membered trans-fused ring skeleton cyclized between the 2'- and 3'-positions of the sugar moiety. Given that the construction of trans-5,6-fused ring skeletons is synthetically challenging, the synthesis was optimized and a detailed structural analysis of these new bridged 2',3'-trans-BNA systems was conducted. The 2',3'-trans-BNAs could be synthesized from a commercially available D-glucose derivative with the key intramolecular gold-catalyzed cyclization reaction achieved using a cyclization precursor bearing an intramolecular hydroxy group and an internal alkyne. Structural analysis of the 2',3'-trans-BNAs showed an N-type sugar conformation for all the derivatives, which is similar to that in RNA-duplex, and the ζ and α torsion angles for the 2',3'-trans-BNAs were a characteristic feature of the compounds that differ from the corresponding angles of the natural duplexes.

Identifiers

PMID40121355
PMCPMC11929919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.